Assessment by quantitative ultrasonometry of the effects of hormone replacement therapy on bone mass

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 3, 2000, Pages 529-534

  Hadji, Peyman ^a   Hars, Olaf ^b   Schüler, Mathias ^a   Bock, Karin ^a   Wüster, Christian ^c   Emons, Günther ^a   Schulz, Klaus D ^c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Estrogen; Hormone replacement therapy; Osteoporosis; Ultrasonography

Indexed keywords

ESTROGEN; HORMONE;

ACCURACY; ADULT; AGED; ARTICLE; BONE MASS; ECHOGRAPHY; FEMALE; HEEL; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 0034081616     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.104204     Document Type: Article

References (52)

1. 1. National Institutes of Health conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 1991;114:593-7.
2. 2. Kanis JA, Devogelaer JP, Gennari C. Practical guide for the use of bone mineral measurements in the assessment of treatment of osteoporosis: a position paper of the European foundation for osteoporosis and bone disease. The Scientific Advisory Board and the Board of National Societies. Osteoporos Int 1996;6:256-61.
3. 3. Hans D, Schott AM, Meunier PJ. Ultrasonic assessment of bone: a review. Eur J Med 1993;2:157-63.
4. 4. Gluer CC. Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. J Bone Miner Res 1997;12:1280-8.
5. 5. Kang C, Speller R. Comparison of ultrasound and dual energy x-ray absorptiometry measurements in the calcaneus. Br J Radiol 1998;71:861-7.
6. 6. Greenspan SL, Bouxsein ML, Melton ME, Kolodny AH, Clair JH, DeLucca PT, et al. Precision and discriminatory ability of calcaneal bone assessment technologies. J Bone Miner Res 1997;12:1303-13.
7. 7. Zerahn B, Borgwardt A, Hejsgard C, Lemser T. Ultrasound and BMD measurements of the os calcis in normal Danish adults. Eur J Exp Musculoskel Res 1996;4:154-9.
8. 8. Han S, Medige J, Faran K, Feng Z, Ziv I. The ability of quantitative ultrasound to predict the mechanical properties of trabecular bone under different strain rates. Med Eng Phys 1997;9: 742-7.
9. 9. Hodgskinson R, Njeh CF, Currey JD, Langton CM. The ability of ultrasound velocity to predict the stiffness of cancellous bone in vitro. Bone 1997;21:183-90.
10. 10. Cheng S, Tylavsky F, Carbone L. Utility of ultrasound to assess risk of fracture. J Am Geriatr Soc 1997;45:1382-94.
11. 11. Gregg EW, Kriska AM, Salamone LM, Roberts MM, Anderson SJ, Ferrell RE, et al. The epidemiology of quantitative ultrasound: a review of the relationships with bone mass, osteoporosis and fracture risk. Osteoporos Int 1997;7:89-99.
12. 12. Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 1996;348:511-4.
13. 13. Bauer DC, Gluer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, et al. Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. Arch Intern Med 1997;157:629-34.
14. 14. Schott AM, Weill-Engerer S, Hans D, Duboeuf F, Delmas PD, Meunier PJ. Ultrasound discriminates patients with hip fracture equally well as dual energy x-ray absorptiometry and independently of bone mineral density. J Bone Miner Res 1995;10:243-9.
15. 15. Cepollaro C, Gonnelli S, Pondrelli C, Martini S, Montagnani A, Rossi S, et al. The combined use of ultrasound and densitometry in the prediction of vertebral fracture. Br J Radiol 1997;70: 691-6.
16. 16. Turner CH, Peacock M, Timmerman L, Neal JM, Johnston CC Jr. Calcaneal ultrasonic measurements discriminate hip fracture independently of bone mass. Osteoporos Int 1995;5:130-5.
17. 17. Gambacciani M, Spinetti A, De Simone L, et al. Postmenopausal bone loss of the proximal femur: estimated contributions of menopause and aging [abstract]. Menopause 1995;2:169.
18. 18. Garnero P, Delmas PD. Biochemical markers of bone turnover. Endocrinol Metab Clin North Am 1998;27:303-23.
19. 19. Christiansen C. Hormone replacement therapy and osteoporosis. Maturitas 1996;23 Suppl:S71-6.
20. 20. O'Connell, Robertson DJ, Henry D, Gillespie W. A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects. Climacteric 1998;1:112-3.
21. 21. Riis B, Thomsen K, Strom V, Christiansen C. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol 1987;156:61-5.
22. 22. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial [published erratum appears in JAMA 1995;274:1676]. JAMA 1995;273:199-208.
23. 23. Field CS, Ory SJ, Wahner HW, Herrmann RR, Judd HL, Riggs BL. Preventive effects of transdermal 17b-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial. Am J Obstet Gynecol 1993;168:114-21.
24. 24. Genant HK, Lucas J, Weiss S, Akin M, Emkey R, McNaney-Flint H, et al. Low-dose esterified estrogen therapy. Arch Intern Med 1997;157:2609-15.
25. 25. Kohrt WM, Birge SJ. Differential effects of estrogen treatment on bone mineral density of the spine, hip, wrist, and total body in late postmenopausal women. Osteoporos Int 1995;5:150-5.
26. 26. Michaelsson K, Baron JA, Farahmand BY, Johnell O, Magnusson C, Persson PG, et al. Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group. BMJ 1998;316:1858-63.
27. 27. Kiel DP, Felson DT, Anderson JJ, Wilson PW, Moskowitz MA. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med 1987;317:1169-74.
28. 28. Cauley JA, Seeley DG, Browner WS, Ensrud K, Kuller LH, Lipschutz RC, et al. Estrogen replacement therapy and mortality among older women. The study of osteoporotic fractures. Arch Intern Med 1997;157:2181-7.
29. 29. Naessén T, Mallmin H, Ljunghall S. Heel ultrasound in women after long-term ERT compared with bone densities in the forearm, spine and hip. Osteoporos Int 1995;5:205-10.
30. 30. Beckmann MW, Mohrmann T, Jap D, Tutschek B, Bodden-Heidrich R, Dadze AG, Crombach G. Knochendichtemessung mittles ultraschalldensitometrie - ergebnisse einer pilotstudie. Zentralbl Gynakol 1998;120:269-74.
31. 31. Balikian P, Burbank K, Houde J, Crane G, Nairus J, Ahmadi S, Baran DT. Bone mineral density and broadband ultrasound attenuation with estrogen treatment of postmenopausal women. J Clin Densitometry 1998;1:19-26.
32. 32. Wasnich R, Yano K, Vogel J. Postmenopausal bone loss at multiple skeletal sites: relationship to estrogen use. J Chronic Dis 1983;36:781-90.
33. 33. Ensrud KE, Palermo L, Black DM, Cauley J, Jergas M, Orwoll ES, et al. Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res 1995;10:1778-87.
34. 34. Davis JW, Ross PD, Johnson NE, Wasnich RD. Estrogen and calcium supplement use among Japanese-American women: effects upon bone loss when used singly and in combination. Bone 1995;17:369-73.
35. 35. Svendsen OL, Hassager C, Marslew U, Christiansen C. Changes in calcanean bone mineral occurring spontaneously and during hormone replacement therapy in early post-menopausal women. Scand J Clin Lab Invest 1992;52:831-6.
36. 36. Wasnich RD, Ross PD, Davis JW, Vogel JM. Etidronate increases bone mass: a longitudinal comparison of skeletal sites. In: Christiansen C, Overgaard K, editors. Osteoporosis 1990. Copenhagen: Osteopress APS; 1990. p. 1396-8.
37. 37. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329:1141-6.
38. 38. Schneider DL, Barrett-Connor EL, Morton DJ. Timing of postmenopausal estrogen for optimal bone mineral density: the Rancho Bernardo Study. JAMA 1997;277:543-7.
39. 39. van Daele PL, Burger H, Algra D, Hofman A, Grobbee DE, Birkenhäger JC, et al. Age-associated changes in ultrasound measurements of the calcaneus in men and women: the Rotterdam Study. J Bone Miner Res 1994;9:1751-7.
40. 40. Wuster C, Soballa T, Heilmann P, Schlegel J, Cadossi R, Ziegler R. Use of ultrasonography in clinical practice: normative data and discrimination power in osteoporosis. Menopause Rev 1997;4:457-65.
41. 41. Karlsson MK, Obrant KJ, Nilsson BE, Johnell O. Bone mineral density assessed by quantitative ultrasound and dual energy x-ray absorptiometry. Acta Orthop Scand 1998;69: 189-93.
42. 42. Kawana K, Kushida K, Takahashi M, Ohishi T, Yamazaki K, Inoue T. Factors related to the parameters of ultrasound measurements in the early menopausal period. Calcif Tissue Int 1997;61:443-4.
43. 43. Kawana K, Kushida K, Takahashi M, Ohishi T, Denda M, Yamazaki K, et al. The effect of menopause on biochemical markers and ultrasound densitometry in healthy females. J Bone Miner Res 1994;55:420-5.
44. 44. Waud CE, Lew R, Baran DT. The relationship between ultrasound and densitometric measurements of bone mass at the calcaneus in women. Calcif Tissue Int 1992;51:415-8.
45. 45. Gonnelli S, Cepollaro C, Pondrelli C, Martini S, Rossi S, Gennari C. Ultrasound parameters in osteoporotic patients treated with salmon calcitonin: a longitudinal study. Osteoporos Int 1996;6:303-7.
46. 46. Gonnelli S, Cepollaro C, Pondrelli C, Montagnani A, Bruni D, Monaco R, et al. Ultrasound parameters in the follow up of osteoporotic women treated with estrogen [abstract]. Osteoporos Int 1998;8 Suppl 3:85.
47. 47. Giorgino R, Paparella P, Lorusso D, Mancuso S. Effects of oral alendronate treatment and discontinuance on ultrasound measurements of the heel in postmenopausal osteoporosis [abstract]. J Bone Miner Res 1996;11 Suppl 1:341.
48. 48. Giorgino R, Paparella P, Lorusso D, Mancuso S. The effects of two different regimens of intramuscular clodronate on os calcis ultrasound densitometry: the results of a two-year prospective study [abstract]. J Bone Miner Res 1997;12 Suppl 1:491.
49. 49. Giorgino R, Paparella P, Lorusso D, Mancuso S. Longitudinal effects of three-year hormonal replacement therapy on quantitative ultrasound bone measurements [abstract]. J Bone Miner Res 1997;12 Suppl 1:S103.
50. 50. Krieg MA, Thiebaud D, Burckhardt P. Effect of calcium and vitamin D3 on bone ultrasound parameters in elderly institutionalized women: a controlled 2 year study [abstract]. J Bone Miner Res 1997;12 Suppl 1:S169.
51. 51. Stepan J, Rosenova Z. Comparison of 17b-estradiol and calcitonin in treatment of postmenopausal bone loss [abstract]. J Bone Miner Res 1997;12 Suppl 1:S351.
52. 52. Cepollaro C, Gonnelli S, Pondrelli C, Martini S, Montagnini, Rossi B, et al. Usefulness of ultrasound in Sudeck's atrophy of the foot. Calcif Tissue Int 1998;62:538-41.